Encouraging Results of Low-Dose Etoposide in the Treatment of Early-Onset Hemophagocytic Syndrome Following Allogeneic Hematopoietic Stem Cell Transplantation
Authors:
- 1 December 2007
- journal article
- letter
- Published by Springer Nature in International Journal of Hematology
- Vol. 86 (5) , 466-467
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Nationwide Survey of Hemophagocytic Lymphohistiocytosis in JapanInternational Journal of Hematology, 2007
- Hemophagocytic syndrome: a rare complication of allogeneic nonmyeloablative hematopoietic stem cell transplantationBone Marrow Transplantation, 2002
- Requirement for Etoposide in the Treatment of Epstein-Barr Virus–Associated Hemophagocytic LymphohistiocytosisJournal of Clinical Oncology, 2001
- Graft Failure Due to Hemophagocytic Syndrome After Autologous Peripheral Blood Stem Cell TransplantationInternational Journal of Hematology, 2001
- Early onset of hemophagocytic syndrome following allogeneic bone marrow transplantation.2000
- Fulminant, CMV-associated, haemophagocytic syndrome following unrelated bone marrow transplantationBone Marrow Transplantation, 1998
- Adenovirus-related hemophagocytic syndrome after bone marrow transplantation.1990